Clinical Trials
61 trialsInvestigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
Norroy Bioscience Co., LTD
inMMyCAR
Kelonia Therapeutics, Inc.
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
TT-CSP-001
TOLREMO therapeutics AG
GPC3
RayzeBio, Inc.
CLEAR
Harbinger Health
BA-004
bioAffinity Technologies Inc.
LEGIT_MC_EVCDA
AI Labs Group S.L
PROCARES
Harbinger Health
PROSTest_STRAT
Wren Laboratories LLC
Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses
Cosmetique Active International
FIRSTLUNG
Delfi Diagnostics Inc.
A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC
Anbogen Therapeutics, Inc.
ColoSense Post-Approval Study
Geneoscopy, Inc.
Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)
MiWEndo Solutions S.L.
MAPLE-UK
Hvivo
Spotlight
Blue Earth Diagnostics
REVELATE
Blue Earth Diagnostics
PREDICT
Gold Standard Phantoms
A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).
Anaveon AG
PURSUE
Blue Earth Diagnostics
APCaRI-05
Nanostics
Cytophone
Cytoastra
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
Blue Earth Diagnostics
First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies
Chimagen Biosciences, Ltd
ANV419-001
Anaveon AG
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
Proteocyte Diagnostics Inc.
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTEâ„¢
Proteocyte Diagnostics Inc.
Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs
Oncoliq US Inc
Collection of Biological Specimens and Associated Health Information
Ovation.io, Inc.
A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Anaveon AG
TIMAR1
Perspective Therapeutics
Evaluation of the Sentinelâ„¢ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico
miR Scientific LLC
MiWEndo1
MiWEndo Solutions S.L.
OSPREY
Progenics Pharmaceuticals, Inc.
CAPTIVE
DNAtrix, Inc.
CONDOR
Progenics Pharmaceuticals, Inc.
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Exact Sciences Corporation
DBT
Siemens Medical Solutions USA - CSG
RITE-USA
Medical Enterprises Ltd.
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Celgene
Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
Biomoda Inc.
A Multi-Center Trial of the ProLung Testâ„¢
Fresh Medical Laboratories
Expanded Access to ABT-414
AbbVie
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
GE Healthcare
proSPECT-AS
Molecular Insight Pharmaceuticals, Inc.
Melanoma Image Analysis Algorithm (MIAA) Validation Study
Skin Analytics Limited
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
Hebei Senlang Biotechnology Inc., Ltd.
Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Jazz Pharmaceuticals
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Novartis